Pharma Project India GSK to Build Pharmaceutical Manufacturing Facility

Editor: Dominik Stephan

Glaxo Smith Kline (GSK) has recently announced its plan to build a new factory. For this upcoming facility the company is expected to invest Rs. 864 crore. The company will partner with local design and construction companies to build a state-of-the-art manufacturing facility which is expected to benefit from leading edge technologies including continuous manufacturing and automated systems.

Related Vendors

Glaxo Smith Kline to build pharma plant in India
Glaxo Smith Kline to build pharma plant in India
(Picture: PROCESS)

Mumbai/India - When complete, the new factory will make pharmaceutical products for the Indian market at a rate of up eight billion tablets and one billion capsules a year. The facility, expected to be operational by 2017, will also include a warehouse, site infrastructure and utilities to support the manufacturing and packing of the medicines.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:42479970)